EFPIA Supports Uniform Approach By EU Member States On Remote Batch Certification
Requirement For MIA Holders To Demonstrate Time Spent By QPs On Site Raises Concern
Executive Summary
The European federation of research-based drug companies has made suggestions to ensure the consistent adoption of an EU proposal that seeks to continue the flexibilities that were introduced in response to COVID-19-related travel restrictions.
You may also be interested in...
Batch Testing ‘Could Double’ Under Govt Proposals For Great Britain
The UK government is consulting on a set of options for batch testing of imported medicines as it seeks to balance patient safety principles with the need to avoid overly burdensome import requirements.
EMA Proposes Extending Remote QP Batch Certification Post-Pandemic
Stakeholders given one month to weigh in on proposal to allow relaxations introduced in response to COVID-19-related travel restrictions to continue on a routine basis.
EMA To Update Active Substances Guide To Address Nitrosamine Contamination
The European Medicines Agency wants to make it clearer for drug sponsors what more they can do to address the presence of cancer-causing impurities in active substances, and how to deal with the issue in their regulatory submissions.